Stop billions in money: pharmaceutical companies cut investments - federal government defends course

The pharmaceutical companies Boehringer Ingelheim and Eli Lilly have announced that they will stop high investments in Germany and are justifying this with austerity requirements from Berlin. Now the federal government is speaking out.